| Financial Year |
March 31 2023 |
| Monetary Funds |
6,562,740,730.97 |
| Held-for-trading Financial Assets |
800,000,000.00 |
| Notes Receivable |
-- |
| Accounts Receivable |
1,784,708,155.11 |
| Advances to Suppliers |
98,368,786.98 |
| Other Receivables |
262,726,713.43 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
682,499,184.11 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
100,293,624.71 |
| Total Current Assets |
10,291,337,195.31 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
11,318,277.05 |
| Fixed Assetes |
3,512,668,328.78 |
| Under-construction Projects |
565,916,974.17 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
817,276,025.18 |
| R&D expenses |
-- |
| Goodwill |
5,884,992,972.40 |
| Long-Term Deferred and Prepaid Expenses |
1,217,982,439.85 |
| Deferred Income Tax Assets |
400,113,222.20 |
| Other Non-Current Assets |
103,928,761.33 |
| Sub-Total of Non-Current Assets |
18,068,852,122.86 |
| Total Assets |
28,360,189,318.17 |
| Short-Term Loans |
575,136,846.13 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
1,894,040,699.09 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
584,828,840.65 |
| Taxes Payable |
313,814,233.76 |
| Interest Payable |
-- |
| Dividend Payable |
4,557,000.00 |
| Other payables |
1,700,576,648.36 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
641,536,271.44 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
5,936,819,609.23 |
| Long-term Loans |
125,360,041.95 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
35,454,651.62 |
| Deferred Income Tax Liabilities |
121,263,439.29 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
3,821,014,878.84 |
| Total Liabilities |
9,757,834,488.07 |
| Paid-In Capital(Or Share Stock) |
7,176,525,335.00 |
| Capital Surplus |
4,008,913,024.76 |
| Surplus Reserve |
976,675,048.98 |
| LESS:Treasury Stock |
1,338,426,796.35 |
| Undistributed Profits |
6,744,505,660.36 |
| Minority Stockholder's Interest |
1,094,367,812.29 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
17,507,987,017.81 |
| Owner's Equity（Stockholder's Equity） |
18,602,354,830.10 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
28,360,189,318.17 |
